Evidence map›Paper›PMID 9573239›Full record

ArticleJournal of virology1998

Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.

T J Wrona, M Lozano, A A Binhazim, J P Dudley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Infection of cells of human embryonal kidneys by mouse mammary tumor virus (MMTV).Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

T J WronaDepartment of Microbiology and Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA.
M Lozano
A A Binhazim
J P Dudley
The University of Texas at Austin · USThe University of Texas MD Anderson Cancer Center · US

Funding

TRANSCRIPTIONAL REGULATION AND TUMORIGENESIS BY MMTVR01CA034780 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI DUDLEY, JAQUELIN PAGE · 1985 to 2002
$821k
SUPERANTIGEN FUNCTION IN MMTV INFECTIONR01CA052646 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI DUDLEY, JAQUELIN PAGE · 1993 to 1997
–
TRAINING PROGRAM IN CANCER BIOLOGYT32CA009583 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI BOSE, HENRY R · 1988 to 1999
–
NCI NIH HHS R01 CA34780NCI NIH HHS R01 CA52646NCI NIH HHS T32 CA009583NCI NIH HHS T32 CA09583
6 · The paper itself

Abstract

The mouse mammary tumor virus (MMTV) encodes within the U3 region of the long terminal repeat (LTR) a protein known as the superantigen (Sag). Sag is needed for the efficient transmission of milk-borne virus from the gut to target tissue in the mammary gland. MMTV-infected B cells in the gut express Sag as a type II transmembrane protein that is recognized by the variable region of particular beta chains (Vbeta) of the T-cell receptor (TCR) on the surface of T cells. Recognition of Sag by particular TCRs results in T-cell stimulation, release of cytokines, and amplification of MMTV infection in lymphoid cells that are needed for infection of adolescent mammary tissue. Because the C-terminal 30 to 40 amino acids of Sag are variable and correlate with recognition of particular TCR Vbeta chains, we prepared a series of C-terminal Sag mutations that were introduced into a cloned infectious MMTV provirus. Virus-producing XC rat cells were used for injection of susceptible BALB/c mice, and these mice were monitored for functional Sag activity by the deletion of C3H MMTV Sag-reactive (CD4+ Vbeta14+) T cells. Injected mice also were analyzed for mutant infection and tumor formation in mammary glands as well as milk-borne transmission of MMTV to offspring. Most mutations abrogated Sag function, although one mutation (HPA242) that changed the negative charge of the extreme C terminus to a positive charge created a weaker Sag that slowed the kinetics of Sag-mediated T-cell deletion. Despite the lack of Sag activity, many of the sag mutant viruses were capable of sporadic infections of the mammary glands of injected mice but not of offspring mice, indicating that functional Sag increases the probability of milk-borne MMTV infection. Furthermore, although most viruses encoding nonfunctional Sags were unable to cause mammary tumors, tumors were induced by such viruses carrying mutations in a negative regulatory element that overlaps the sag gene within the LTR, suggesting that loss of Sag function may be compensated, at least partially, by loss of transcriptional suppression in certain tissues. Together these results confirm the importance of Sag for efficient milk-borne transmission and indicate that the entire C-terminal region is needed for complete Sag function.

Indexed as

Amino Acid SequenceAnimalsDNA Mutational AnalysisDNA, ViralFemaleGenes, ViralMammary Tumor Virus, MouseMiceMice, Inbred BALB CMice, Inbred C3HMolecular Sequence DataMutationRatsReceptors, Antigen, T-Cell, alpha-betaRetroviridae InfectionsSequence AlignmentDNA, ViralReceptors, Antigen, T-Cell, alpha-betaSuperantigens

Identifiers

PMID9573239
PMCPMC110007
OpenAlexW1590972182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.